
Chinese biopharmaceutical company founded in 2010 in Xuhui, Shanghai within the Fosun Pharma group, developing, manufacturing and marketing monoclonal antibody medicines for oncology, autoimmune and ophthalmic disease, including biosimilars and its own innovative antibodies, with products approved in China and overseas.
View Company Profile
Leave your rating